Abstract

Recently, the number of water insoluble and poorly soluble drug compounds has increased significantly. Therefore, growing interest has been witnessed in different particle size reduction techniques to improve the dissolution rates, transport characteristics and bioavailability of drugs. Laser ablation has proven to be an alternative method to the production of nano- and micrometre-sized drug particles without considerable chemical damage. We present the nanosecond laser ablation of drug pastilles in distilled water, targeting meloxicam, a poorly water soluble nonsteroidal anti-inflammatory drug, at different laser wavelengths (248 nm, 532 nm and 1064 nm). Besides chemical characterization, crystallinity, morphology and particle size studies, the mechanism of the particle generation process was examined. The applicability of ablated particles in drug formulation was investigated by solubility, cytotoxicity and anti-inflammatory effect measurements. We showed that laser ablation is a clean, efficient and chemically non-damaging method to reduce the size of meloxicam particles to the sub-micrometre–few micrometre size range, which is optimal for pulmonary drug delivery. Complemented by the excellent solubility (four to nine times higher) and anti-inflammatory (four to five times better) properties of the particles compared to the initial drug, laser ablation is predicted to have wider applications in the development of drug formulations.

Details

Title
A comprehensive analysis of meloxicam particles produced by nanosecond laser ablation as a wet milling technique
Author
Nagy, Eszter 1 ; Homik, Zsolt 1 ; Smausz, Tamás 1 ; Kopniczky, Judit 1 ; Náfrádi, Máté 2 ; Alapi, Tünde 2 ; Kokai, David 3 ; Burián, Katalin 3 ; Szabó-Révész, Piroska 4 ; Ambrus, Rita 4 ; Hopp, Béla 1 

 University of Szeged, Department of Optics and Quantum Electronics, Szeged, Hungary (GRID:grid.9008.1) (ISNI:0000 0001 1016 9625) 
 University of Szeged, Department of Inorganic and Analytical Chemistry, Szeged, Hungary (GRID:grid.9008.1) (ISNI:0000 0001 1016 9625) 
 University of Szeged, Department of Medical Microbiology, Albert Szent-Györgyi Medical School, Szeged, Hungary (GRID:grid.9008.1) (ISNI:0000 0001 1016 9625) 
 University of Szeged, Institute of Pharmaceutical Technology and Regulatory Affairs, Szeged, Hungary (GRID:grid.9008.1) (ISNI:0000 0001 1016 9625) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2692912088
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.